Sign up
Pharma Capital

Namaste Technologies Inc awaiting sales license as plans to up-list on the Nasdaq

Namaste Technologies Inc (CVE:N, OTCQB:NXTTF) CEO Sean Dollinger tells Proactive Investors the cannabis e-commerce company's plan to up-list to the Nasdaq is pushing along.

Dollinger says the company is awaiting its sales license to sell cannabis online, which he says should come anytime now. He believes this will be the catalyst to move the company to US$4 per share, the minimum share price to list on a major exchange.

After recording the interview, Dollinger reacted to Andrew Left's comment from Citron Research calling Namaste's shares 'joke.' Dollinger fired back at Left saying, "we’ll prove to him that he’s the joke.”

 

View full N profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.